Skip to main content
Premium Trial:

Request an Annual Quote

Incyte and Gene Logic Dismiss Patent Suit, Gene Logic Granted License

NEW YORK, Jan 11 - Incyte Genomics and Gene Logic have settled a patent infringement lawsuit filed by Incyte against Gene Logic, the companies said Thursday.

The suit, filed in the U. S. District Court for the Northern District of California, alleged infringement of U.S. Patent Numbers 5,716,785, 5,891,636 and 6,023,659.

Under the settlement agreement, the lawsuits will be dismissed and Gene Logic will have a non-exclusive license to practice the technology described in these patents.

Specific settlement and financial terms were not disclosed, in accordance with the terms of the settlement agreement.

U.S. Patents 5,716,785 and 5,891,636, both entitled “Processes for genetic manipulations using promoters,” cover the use of promoters for RNA amplification and other genetic manipulations.

U. S. Patent 6,023,659, “Database system employing protein function hierarchies for viewing biomolecular sequence data,” covers a relational database system that stores biomolecular sequence information so that it may be catalogued and searched according to one or more protein function hierarchies.
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.